Arvinas (ARVN) Total Liabilities (2017 - 2026)

Arvinas' (ARVN) quarterly Total Liabilities came in at $260.7 million in Q1 2026, down 23.55% year-on-year from $341.0 million in Q1 2025, and down 8.2% quarter-over-quarter from $284.0 million in Q4 2025.

Arvinas (ARVN) Total Liabilities (2017 - 2026) Analysis & Trends

Arvinas' Total Liabilities history runs 10 years deep, the most recent figure standing at $260.7 million for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 23.55% year-over-year to $260.7 million in Q1 2026; TTM through Mar 2026 was $260.7 million, a 23.55% decrease from a year earlier, with the FY2025 full-year figure at $284.0 million, down 46.38% from the prior year.
  • Total Liabilities retreated to $260.7 million in Q1 2026 per ARVN's latest filing, from $284.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $765.0 million in Q1 2022 and bottomed at $260.7 million in Q1 2026.
  • The 5-year median for Total Liabilities is $602.9 million (2024), against an average of $547.5 million.
  • Across the five-year window, Total Liabilities jumped 1105.64% in 2022 and plunged 55.84% in 2025, its largest moves.
  • Year by year, Total Liabilities stood at $703.9 million in 2022, then dropped by 8.42% to $644.6 million in 2023, then dropped by 17.83% to $529.7 million in 2024, then slumped by 46.38% to $284.0 million in 2025, then fell by 8.2% to $260.7 million in 2026.
  • Per Business Quant, the three latest ARVN Total Liabilities figures stand at $260.7 million (Q1 2026), $284.0 million (Q4 2025), and $279.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 60.46 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 177.22 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 19.51 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 3.79 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.48 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 753.82 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 260.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 260.70 Mn
Dec 31, 2025 284.00 Mn
Sep 30, 2025 279.90 Mn
Jun 30, 2025 300.00 Mn
Mar 31, 2025 341.00 Mn
Dec 31, 2024 529.70 Mn
Sep 30, 2024 581.10 Mn
Jun 30, 2024 679.40 Mn
Mar 31, 2024 602.90 Mn
Dec 31, 2023 644.60 Mn
Sep 30, 2023 601.10 Mn
Jun 30, 2023 619.90 Mn
Mar 31, 2023 664.80 Mn
Dec 31, 2022 703.90 Mn
Sep 30, 2022 713.30 Mn
Jun 30, 2022 736.40 Mn
Mar 31, 2022 765.00 Mn
Dec 31, 2021 799.90 Mn
Sep 30, 2021 787.13 Mn
Jun 30, 2021 61.08 Mn